Charles River utilizes a truly integrated approach to small molecule drug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team. As an experienced drug discovery organization, we are able to tailor project resources to meet the client's specific needs, integrating chemistry, physical sciences, CADD, biology, structural biology, ADMET/PK and disease models as required.

Rethinking the Role of a CRO

Nature spoke with Dr. Emily Hickey, our Corporate Senior VP of Global Discovery, about our expanded portfolio and scientific track record. Read article »

I need to...